OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The JAK-STAT Pathway as a Therapeutic Strategy in Cancer Patients with Immune Checkpoint Inhibitor-Induced Colitis: A Narrative Review
Antonietta Gerarda Gravina, Raffaele Pellegrino, Alfonso Esposito, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 611-611
Open Access | Times Cited: 13
Antonietta Gerarda Gravina, Raffaele Pellegrino, Alfonso Esposito, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 611-611
Open Access | Times Cited: 13
Showing 13 citing articles:
Natural products for the treatment of ulcerative colitis: focus on the JAK/STAT pathway
Dan Long, Chenhan Mao, Wei Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Dan Long, Chenhan Mao, Wei Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Gastrointestinal toxicities associated with immune checkpoint inhibitors therapy: risks and management
Conrad Russell Y. Cruz, Maria José Albuquerque Santos, Sharada Wali, et al.
Immunotherapy (2025), pp. 1-11
Closed Access | Times Cited: 1
Conrad Russell Y. Cruz, Maria José Albuquerque Santos, Sharada Wali, et al.
Immunotherapy (2025), pp. 1-11
Closed Access | Times Cited: 1
Immune checkpoint inhibitor-induced diarrhea and colitis: an overview
Marianne Zoghbi, Kathryn J Burk, Elio Haroun, et al.
Supportive Care in Cancer (2024) Vol. 32, Iss. 10
Open Access | Times Cited: 7
Marianne Zoghbi, Kathryn J Burk, Elio Haroun, et al.
Supportive Care in Cancer (2024) Vol. 32, Iss. 10
Open Access | Times Cited: 7
Small Molecules in the Treatment of Acute Severe Ulcerative Colitis: A Review of Current Evidence
Raffaele Pellegrino, Giuseppe Imperio, Ilaria De Costanzo, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 308-308
Open Access
Raffaele Pellegrino, Giuseppe Imperio, Ilaria De Costanzo, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 308-308
Open Access
Restore intestinal steady-state: new advances in the clinical management of chemotherapy-associated diarrhea and constipation
Miaoqi Chen, Yamao Li, Peijun Chen
Journal of Molecular Histology (2025) Vol. 56, Iss. 2
Open Access
Miaoqi Chen, Yamao Li, Peijun Chen
Journal of Molecular Histology (2025) Vol. 56, Iss. 2
Open Access
BAIAP2L2 facilitates hepatocellular carcinoma progression and immune evasion of via targeting JAK1-mediated pathway and PD-L1 expression
Zhiyue Xie, Yanxia Wu, Nan Peng, et al.
Cancer Gene Therapy (2025)
Closed Access
Zhiyue Xie, Yanxia Wu, Nan Peng, et al.
Cancer Gene Therapy (2025)
Closed Access
Decoy oligodeoxynucleotides targeting STATs in non-cancer gene therapy
Maryam Mahjoubin‐Tehran, Samaneh Rezaei, Prashant Kesharwani, et al.
Gene (2025), pp. 149482-149482
Closed Access
Maryam Mahjoubin‐Tehran, Samaneh Rezaei, Prashant Kesharwani, et al.
Gene (2025), pp. 149482-149482
Closed Access
Are Small Molecules Effective in Treating Inflammatory Pouch Disorders Following Ileal Pouch-Anal Anastomosis for Ulcerative Colitis? Here Is Where We Stand
Antonietta Gerarda Gravina, Raffaele Pellegrino, Giovanna Palladino, et al.
Biomolecules (2024) Vol. 14, Iss. 9, pp. 1164-1164
Open Access | Times Cited: 3
Antonietta Gerarda Gravina, Raffaele Pellegrino, Giovanna Palladino, et al.
Biomolecules (2024) Vol. 14, Iss. 9, pp. 1164-1164
Open Access | Times Cited: 3
Circular RNAs and the JAK/STAT pathway: New frontiers in cancer therapeutics
Waleed Hassan Almalki, Salem Salman Almujri
Pathology - Research and Practice (2024) Vol. 260, pp. 155408-155408
Closed Access | Times Cited: 2
Waleed Hassan Almalki, Salem Salman Almujri
Pathology - Research and Practice (2024) Vol. 260, pp. 155408-155408
Closed Access | Times Cited: 2
Masashi Kono, Yoriaki Komeda, Hisato Kawakami, et al.
Cancer Reports (2024) Vol. 7, Iss. 10
Open Access | Times Cited: 2
Fulminant immune-related colitis after dual checkpoint inhibitor therapy: case report
Robert R. Lukin, Aaron Ciner
Immunotherapy (2024) Vol. 16, Iss. 14-15, pp. 943-948
Closed Access | Times Cited: 1
Robert R. Lukin, Aaron Ciner
Immunotherapy (2024) Vol. 16, Iss. 14-15, pp. 943-948
Closed Access | Times Cited: 1
The growing potential of tofacitinib in immune checkpoint inhibitor-induced colitis: identifying remaining puzzle pieces
Raffaele Pellegrino, Giovanna Palladino, Giuseppe Imperio, et al.
Exploration of Immunology (2024), pp. 770-779
Open Access
Raffaele Pellegrino, Giovanna Palladino, Giuseppe Imperio, et al.
Exploration of Immunology (2024), pp. 770-779
Open Access
CD8+ cell dominance in immune checkpoint inhibitor-induced colitis and its heterogeneity across endoscopic features
Min Kyu Kim, Hye‐Nam Son, Seung Wook Hong, et al.
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access
Min Kyu Kim, Hye‐Nam Son, Seung Wook Hong, et al.
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access
